Sartorius Aktiengesellschaft (SSSGY)
OTCMKTS · Delayed Price · Currency is USD
42.51
+0.40 (0.95%)
At close: May 8, 2025
SSSGY Revenue
Sartorius Aktiengesellschaft had revenue of 883.00M EUR in the quarter ending March 31, 2025, with 7.74% growth. This brings the company's revenue in the last twelve months to 3.44B, up 3.99% year-over-year. In the year 2024, Sartorius Aktiengesellschaft had annual revenue of 3.38B, down -0.44%.
Revenue (ttm)
3.44B EUR
Revenue Growth
+3.99%
P/S Ratio
4.12
Revenue / Employee
254.59K EUR
Employees
13,528
Market Cap
15.34B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.38B | -15.00M | -0.44% |
| Dec 31, 2023 | 3.40B | -779.00M | -18.66% |
| Dec 31, 2022 | 4.17B | 725.50M | 21.03% |
| Dec 31, 2021 | 3.45B | 1.11B | 47.68% |
| Dec 31, 2020 | 2.34B | 508.69M | 27.84% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |